Ontology highlight
ABSTRACT:
SUBMITTER: Cepulyte R
PROVIDER: S-EPMC7584966 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Case reports in hematology 20201015
Multiple myeloma (MM) is an incurable plasma cell neoplasia characterized by relapsed and/or refractory (R/R) disease course, which poses a major therapeutic challenge. New therapies, including BRAF V600E mutation targeting, may become a new treatment option for R/R MM. In combination with mitogen-activated protein kinase inhibitors (MEKi), BRAF inhibitors (BRAFi) could provide better tailored clinical management, although experience in this field is lacking. To this date, there is only one case ...[more]